Skip to main content
Clinical Trials/NCT01481558
NCT01481558
Completed
Phase 2

Effects of Transcranial Direct Current Stimulation on the Apathy of Alzheimer's: a Randomized, Sham-controlled Clinical Trial

University of Sao Paulo1 site in 1 country40 target enrollmentJanuary 2012

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Apathy
Sponsor
University of Sao Paulo
Enrollment
40
Locations
1
Primary Endpoint
Apathy Symptoms
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

This is a phase 2 double-blind, randomized, sham-controlled study to investigate the effects of repeated transcranial direct current stimulation for the treatment of apathy in moderate Alzheimer's Disease in patients selected from an outpatient clinics in São Paulo, Brazil.

Detailed Description

Forty patients were randomized to receive either active or sham-tDCS over the left dorsolateral prefrontal cortex (DLPFC). Patients received six sessions of intervention during two weeks and were evaluated at baseline, at week one and two, and after one week without intervention. Clinical raters, patients, and caregivers were blinded. The primary outcome was apathy. Global cognition and neuropsychiatric symptoms were examined as secondary outcomes.

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
May 2012
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Claudia Kimie Suemoto

Assistant Professor

University of Sao Paulo

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Apathy Symptoms

Time Frame: Differences in outcome measure comparing second week to baseline

Apathy evaluated by Apathy Scale by Starsktein et al, 1992, which consists of 14 items phrased as questions that are to be answered by the caregiver on a four-point Likert scale. The total score range from 0 to 42, with higher scores indicating greater apathy severity. Apathy was assessed at baseline and at the end of the sixth session (second week).

Study Sites (1)

Loading locations...

Similar Trials